For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

Wu draws more small donations from city residents while Kraft attracts larger contributions and significant out-of-state ...

BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform.

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

On the occasion of World Multiple Sclerosis Day, Ad Scientiam announced that MSCopilot ®, its class IIa Software as a Medical Device (SaMD) dedicated to the monitoring of people living with multiple ...

The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost ...